|
HS Code |
219680 |
| Active Ingredient | Naphazoline Nitrate |
| Chemical Formula | C14H14N2·HNO3 |
| Drug Class | Sympathomimetic (alpha-adrenergic agonist) |
| Mechanism Of Action | Vasoconstricts by stimulating alpha-adrenergic receptors |
| Primary Use | Relief of ocular or nasal congestion |
| Route Of Administration | Topical (eye drops, nasal drops/spray) |
| Onset Of Action | A few minutes after administration |
| Duration Of Action | Up to 4-6 hours |
| Appearance | Clear, colorless solution |
| Storage Conditions | Store below 25°C, protect from light |
| Side Effects | Possible irritation, rebound congestion, pupil dilation |
| Contraindications | Hypersensitivity to naphazoline, narrow-angle glaucoma |
| Atc Code | S01GA03 |
| Molecular Weight | 272.28 g/mol |
| Prescription Status | Over-the-counter in many regions |
As an accredited Naphazoline Nitrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Naphazoline Nitrate is packaged in a 25g amber glass bottle with a tamper-evident cap, featuring clear hazard and identification labeling. |
| Shipping | Naphazoline Nitrate should be shipped as a hazardous chemical, in tightly sealed, properly labeled containers, and packed to prevent leakage or contamination. It must be protected from light, heat, and moisture. All shipping must comply with local and international regulations for hazardous substances, including appropriate documentation and handling procedures. |
| Storage | Naphazoline Nitrate should be stored in a tightly closed container, protected from light and moisture. Keep it at room temperature, ideally between 15°C and 30°C (59°F and 86°F), in a well-ventilated area away from heat and sources of ignition. Ensure storage in a secure location, inaccessible to unauthorized personnel, and separate from incompatible substances such as strong oxidizers. |
Applications of Naphazoline Nitrate in Industrial ManufacturingNaphazoline nitrate functions primarily as a sympathomimetic agent in pharmaceutical formulations. Its performance and compliance parameters determine its suitability across tightly regulated downstream sectors. Below, we detail authentic application fields from the perspective of a dedicated chemical manufacturer, outlining process-specific integration and regulatory requirements for downstream producers. 1. Decongestant Nasal Spray FormulationDownstream pharmaceutical companies incorporate this raw material as the core active agent in over-the-counter nasal decongestant sprays. Production lines integrate precise dosing equipment to meet monograph requirements, and all excipient blending occurs in classified cleanrooms. Quality control teams strictly monitor residual solvent levels, active content, and microbial purity as per pharmacopeial protocols. The ingredient enables rapid constriction of blood vessels in nasal mucosa, providing patients with effective relief from congestive symptoms within minutes of application. Each batch receives QC clearance based on finished product uniformity and active content before downstream packaging operations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Ophthalmic Formulation ManufacturingOphthalmic producers use our raw material as a vasoconstrictor in sterile eye drop lines. Formulators combine it with established antimicrobials and buffer agents, ensuring the ophthalmic solution maintains iso-osmolarity and required pH values. Downstream cleanroom conditions meet ISO 14644-1 standards, and every batch undergoes particulate and microbial testing. Finished drops offer short-term redness reduction in the conjunctiva by reducing capillary swelling after patient application. Strict in-process controls during compounding and filling mitigate particle contamination risks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Combination Cold and Allergy Oral ProductsTablet and powder manufacturers use naphazoline nitrate as a sympathomimetic agent in combination formulations for cold and allergy symptoms. Manufacturing lines incorporate it via high-shear blending prior to direct compression or granulation. Finished products combine multiple actives, requiring robust traceability and content uniformity assurance. Quality departments test each lot for blend homogeneity, dissolution profile, and stability under ambient and accelerated conditions to meet global registration dossier data requirements. Labeling and batch release conform to DSCSA (Drug Supply Chain Security Act) mandates for pharmaceutical traceability in the U.S. market. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Intranasal Decongestant SolutionsVeterinary pharmaceutical producers choose our ingredient for formulating nasal decongestants in livestock and companion animal health. Solutions are manufactured following veterinary pharmacopoeia requirements for purity and safety, often involving formulation in isotonic saline with preservatives. Downstream producers maintain batch records to enable adverse effect tracking and recall in case of regulatory audit. Process validation covers dosing consistency and container closure integrity to assure efficacy and shelf-life under field use conditions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Reference Standard Preparation for Analytical LaboratoriesQuality control and reference material suppliers prepare certified standards using pharmaceutical-grade naphazoline nitrate. Analytical laboratories use these reference materials during HPLC, GC, and UV-Vis method validation in regulatory submissions and batch release testing. Downstream manufacturers rigorously calibrate working standards through primary-substance weighing, solubilization in certified solvents, and comparison against international certified reference materials. Final standard vials support lot-release, stability, and impurity testing by pharmaceutical producers and contract analysis labs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Naphazoline Nitrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Day in and day out, we have stood in the chemical plant, where QA teams inspect each run of Naphazoline Nitrate. Our raw materials travel less than 100 miles to reach our doors. A few years ago, sourcing was trickier—cold-chain interruptions left us fighting inconsistencies. With every batch since then, we’ve focused on traceability as strongly as purity. Our Naphazoline Nitrate, offered as Model NN-89, emerges as a crystalline white powder, never blended or diluted prior to shipment. R&D observes every granule for physical uniformity; we reject anything not up to spec before packaging. We’ve settled on a specification that reflects experience and close work with our long-term pharmaceutical clients: content measured by HPLC between 99.2% and 100.4%, moisture below 0.2%, free from residues detectable by modern spectrography. On every run, we test solubility in water to guarantee the level of clarity and the speed of dissolution recognized as essential for downstream pharmaceutical compounding.
Our production method draws on more than a decade of tweaks. Early on, we noticed recurring loss of yield from improper pH adjustment during nitration, so we invested in real-time monitoring. The nitrate’s signature color and response to UV tests signal to the floor team whether to continue or pause a batch. Through painstaking tuning, we avoid both under- and over-nitration—errors that haunted our earlier years and led to visible yellow tint or, worse, off-odors. Each batch’s origin is logged and retraceable. Experience has taught us the ache of discarding half-ton drums for minor impurity—small lessons that now prevent entire lines from shutting down.
Naphazoline Nitrate stands out due to these controls and its reliable supply. The molecule serves primarily in the manufacture of topical nasal and ophthalmic decongestants, prized for rapid vasoconstrictive properties. Pharmaceutical companies appreciate the lot-to-lot consistency for blending with excipients. Several partners tell us about ease of integration into solution-making machinery, remarking on our predictable flow properties and clump resistance, likely due to humidity controls maintained throughout post-processing. We take seriously the feedback we’ve received about granule size and dusting issues—our current sifter settings resulted from years of working with mixing engineers on the client side who demand dust minimization for their workers’ health and safety.
We learned early never to underestimate the difference between theoretical chemistry and actual plant performance. On paper, two samples with 99.5% purity might seem interchangeable. On the ground, time-release tablets or eye drops can show marked variations due to residual solvents or micro-impurities. We remember a day when an uncontrolled run led to increased batch caking, delaying production by 72 hours for one client—expensive for both parties. We have since installed additional air drying and in-line monitoring, along with strict sampling protocols per shift. Our senior operators get called to the floor the instant any strange odor or off-color appears, even in the middle of the night.
Many newcomers to this product assume all naphazoline nitrates are alike. Anyone who’s stood next to a crystallizer or analyzed a failed granule under a microscope knows otherwise. We have observed subtle cue points in texture, particle size, even storage “feel”—an awkward stickiness on a humid day signals issues on the line. Over time, we’ve addressed these through closed-system processing, custom moisture barriers in our packaging, and triple-sealed containers for shipment. Our batch labels carry QR codes tying every drum or carton to its source, production operator, and real-time analytical data from that cycle. This comes from lessons learned in past mix-ups—one investigation traced a microbe issue to a single, undetected equipment maintenance slip.
Years of dialogue with R&D at major pharmaceutical companies led us to develop the NN-89 model as our main commercial offering. Their feedback required fine-tuning not only on purity metrics but also mechanical features that show up during blending, tableting, and final product stability tests. Shifting expectations and new compliance demands force us to modify standard operating procedures regularly. On weekday mornings, our tech team calls in with European, African, and Southeast Asian customers to assess how product ships and performs during humid rainy seasons. We’ve maintained a dedication to adjusting our cycle time and controlling for ambient variables in a way that traders and resellers simply don’t see. A week without these controls can mean a month of complaints ahead.
This compound doesn’t travel well outside strong packaging and tight controls. We’ve lost cartons in transport to accidental moisture exposure; the handled batch eventually formed stubborn clumps, practically useless except as lab material. That’s why we only send shipments with a built-in humidity indicator, and every container packs desiccant sachets. Receiving managers on the pharma side have remarked that our cartons arrive cleaner and with less damage—something we attribute to years of box design changes and staff training. Other producers sometimes use less robust packaging, leading to contamination.
Experienced buyers know the importance of asking about not just analysis certificates, but the actual pre-shipment logs and control records. Our doors have been open many times to partner audits; every time, the feedback sharpens our procedures. Labs that rely on smaller suppliers too often complain of lot drift—subtle shifts from batch to batch, most evident in the flow and blending stage. We maintain a sample from every lot sent, stored under controlled temperature in our own archive, available for side-by-side re-testing in the event of a downstream complaint. This is not just policy but a direct outgrowth of one recall that forced us to re-trace three months of deliverables. Since then, we’ve been fierce about internal record depth.
Markets flood with options for every API, each one promising the highest standard. The real test comes in repeat cycles—delivering the third truckload with the same quality and physical traits as the first. Pharmaceutical formulators have told us about switching to our NN-89 after at least two suppliers failed their stability trials. Several times, our direct competitors have neglected to monitor minor but critical metrics, resulting in compounds that do not dissolve cleanly. The feedback we get most often is relief at the predictability, not only in chemical purity but in every physical touchpoint that matters to the production line operators who use our product.
We don’t believe in racing to the bottom with short-term cost cuts. It’s easy to shave pennies on lesser-grade raw inputs, skip a filter step, or trim QA sampling rates. We have felt the pain from even small lapses: losing entire customer lines for a year or more because shortcuts led to headaches on their side. Unlike third-party traders, we bear the consequences of each issue. Our direct manufacturing means we experience the day-by-day interplay between raw input sourcing, plant performance, equipment reliability, and batch approval—there’s no shield from responsibility if something slips.
A resold drum lacks this level of origin story. When product heads out from our facility, the chain of custody is clear, the handling protocols documented, the entire path from synthesis to packaging visible and inspectable. Many customers, once burned by inconsistency from intermediaries, return to us for this very transparency. Our support team can walk any client through process, maintenance schedules, and non-conformity reports, if requested.
The regulatory environment continues to push for higher standards and compliance updates each year. Over the past five years, we have invested in staff training—each shift lead sits through six days of new compliance coursework annually. We respond to audits, not just locally but with remote support for international partners asking about import compliance. These changes aren’t a one-time fix; new rules come, batch records expand, storage areas grow more monitored, cleaning processes tighten. Operator stress increases, but so does client trust. We pivot our internal reporting, so out-of-spec results surface faster, well before they reach packaging. Our approach has shifted toward digital records, reducing paper forms and speeding traceability.
Sustainability concerns now push us to reduce waste and streamline water use in our process. We recently adopted a closed-loop filtration stage reclaiming 85% of water that would have left as effluent. This step not only cuts disposal fees but ensures a more consistent environment, which in turn stabilizes batch output. Many years ago, before this step, we saw wild swings during high-humidity months—now, batch variances have dropped dramatically. Chemical manufacturing never stands still; incremental improvements stem from each problem that’s thrown at us. We have dealt with workforce illnesses, packaging shortages, and raw material price spikes, all prompting creative, sometimes painful, solutions that improved the product over time.
Conversations with our long-standing clients shape almost every improvement. Some call in to comment on the ease of pouring compared to previous suppliers, while others point out things as simple as easier barcode scanning. One large manufacturer noted that our granule structure cut the time needed for mixer clean-down between product changeovers—this came from us retooling our sieving line. Our goal remains to translate this field-level feedback into operations tweaks, increased automation, and more robust training.
We hire plant-floor workers who learn both from classroom chemistry and hands-on troubleshooting—nobody makes it far in the blending bay without getting dirty and asking tough questions about “why.” We’ve run quarterly “mistake review” meetings. At these, more than once, a small misstep in storage or sample handling has uncovered a bigger process vulnerability. It’s far more effective, over the years, to teach that problems aren’t to be hidden but decoded. Good product comes from good processes; great product comes from people driven by pride and curiosity.
As supply chains have tightened over the past few years, direct communication with materials vendors means fewer surprises. If an input is slow to arrive, we negotiate alternative lots and bring in emergency stocks so downstream runs do not fail for our customers. During the pandemic, chemical logistics went haywire, but because we have fostered deep relationships with our freight handlers, shipments rarely went awry. Our clients rarely saw disruptions, though in a few cases we absorbed storage and demurrage costs ourselves to avoid delays—something only the manufacturer, not an importer, could commit to. These are hidden facets of direct production, often missed in glossy sales proposals.
From the earliest inquiry through end-product complaints, we trace issues back to their true origin. A batch of Naphazoline Nitrate that doesn’t meet expectation doesn’t get shipped; replacements are rapid because backup stock remains on hand and records make pinpointing the problem straightforward. Our procedural discipline means the client’s QA team gets what they expect, every time; any deviation is explained, never hidden. We visit customer plants, examine how their operators use our product, and adjust processes on our side to reduce their risks. It’s not uncommon for our technical team to travel alongside multinational audits or troubleshoot on-site when clients report production stalling, owed sometimes to operator error rather than material quality. We see ourselves not merely as material providers but as participants in a long, mutually demanding chain from synthesis to patient.
A commodity chemical can feel faceless—a bag, a drum, an invoice. We see Naphazoline Nitrate differently, rooted as it is in the scars and successes of direct manufacturing. Each run tells a story of choices: which lot of raw nitrate, which tank for storage, when to upgrade a mixer, how to tweak the batch timing for a new environmental control standard. We have learned the value of clarity: through QA, through client dialogue, through field-level trials that spot small defects early and turn those insights into action on the floor. Each passing year pushes us toward better traceability, higher standards, and more creative solutions for client problems. This plays out in the product itself, in the way plant workers take more care, in every detail from crystallization to carton sealing.
Over time, our deepening technical expertise has become a silent guarantee that clients can rely on. Behind every product specification sits thousands of hours of planning, error-correction, argument, and late-night troubleshooting—a living history, built into the powder itself. Far from a generic API, our Naphazoline Nitrate stands as proof that manufacturing experience, continual improvement, and hard-won trust make the crucial difference where it matters most: in seamless production, safety, and the confidence that every shipment will perform as promised on the user’s end. That is the reality for those working in the heat, light, and pressure of a chemical plant, serving people who depend on every last detail being right.